🕵️ Tuhura Biosciences, INC./NV ($HURA)
SEC insider & ownership activity, last 12 months · CIK 1498382 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 9.1% | 13G | Feb 17, 2026 | filing ↗ | |
| James A. Bianco, M.D. | exited | 13D | Aug 18, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Sep 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing ↗ |
| New financial obligation (2.03) | Sep 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2026 | filing ↗ |
| New financial obligation (2.03) | Aug 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 20, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | Aug 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2026 | filing ↗ |
| Earnings (2.02) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| New financial obligation (2.03) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Jun 17, 2026 | filing ↗ |
| New financial obligation (2.03) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| New financial obligation (2.03) | Apr 21, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |